Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Shares Outstanding (Weighted Average) (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $199.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 4.01% year-over-year to $199.0 million, compared with a TTM value of $199.0 million through Sep 2025, up 4.01%, and an annual FY2024 reading of $190.8 million, up 2.46% over the prior year.
  • Shares Outstanding (Weighted Average) was $199.0 million for Q3 2025 at Alignment Healthcare, up from $196.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $199.0 million in Q3 2025 and bottomed at $181.2 million in Q4 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $189.4 million, with a median of $189.9 million recorded in 2024.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 4.01% in 2025, while the deepest fall reached 2.43% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $181.2 million in 2022, then rose by 2.76% to $186.2 million in 2023, then increased by 2.46% to $190.8 million in 2024, then increased by 4.32% to $199.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ALHC at $199.0 million in Q3 2025, $196.0 million in Q2 2025, and $193.6 million in Q1 2025.